Biocept Inc (NASDAQ: BIOC) today proclaimed a partnership with Quest Diagnostics Inc (NYSE: DGX) to provide research laboratory analysis facilities to Quest patients for its Target Selector™ NGS-based liquid biopsy directed lung cancer section. Quest Diagnostics is the foremost supplier of investigative info facilities, counting in advanced diagnostics. The Biocept […]